Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria del Mar Ayala"'
Autor:
Lain, Nuria Clara Prieto, Hernández, Ana Isabel Gómez, Hernández, Elizabeth Lorenzo, Gómez, Carlos Romero, Gutiérrez, Maria del Mar Ayala, Huelgas, Ricardo Gómez
Publikováno v:
In Revista clinica espanola November 2023 223 Supplement 2:S622-S623
Autor:
Norberto Ortego-Centeno, José Luis Callejas Rubio, Francisco J. García-Hernández, Cristina Lucía Dávila-Fajardo, Maria del Mar Ayala, Raquel Ríos-Fernández, Maria Jesús Castillo Palma, Gema Robledo, Enrique de Ramón Garrido, Javier Martín, Julio Sánchez-Román, Maria Teresa Camps García, Ana Márquez, María Francisca González-Escribano
Publikováno v:
DNA and Cell Biology. 31:1486-1491
Rituximab has become a pivotal treatment for systemic autoimmune diseases. The aim of this study was to determine whether the genetic variant -174 IL-6 contributes to differences in the response to rituximab in patients with systemic autoimmune disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::699b7667e0cdd90ab62128ea0da4f10e
https://doi.org/10.1089/dna.2012.1684
https://doi.org/10.1089/dna.2012.1684
Autor:
Gema Robledo, Ana Márquez, Maria Teresa Camps García, Cristina Lucía Dávila-Fajardo, Maria del Mar Ayala, Francisco J. García-Hernández, Enrique de Ramón Garrido, Javier Martín, Raquel Ríos-Fernández, Norberto Ortego-Centeno, Maria Jesús Castillo Palma, María Francisca González-Escribano, Julio Sánchez-Román, José Luis Callejas Rubio
Publikováno v:
DNA and cell biology. 31(12)
Rituximab is being used as treatment for systemic autoimmune diseases. The objective of this study was to determine whether the genetic variant in the Fc gamma-receptor III a (FCGR3A) gene, 158F/V, contributes to the observed variation in response to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a72e81a56fddc0e758145754fd0256
https://pubmed.ncbi.nlm.nih.gov/23075294
https://pubmed.ncbi.nlm.nih.gov/23075294